27/08/2015 L'Agenzia Italiana del Farmaco rende note importanti informazioni di sicurezza per il corretto uso della quetiapina nel trattamento della depressione bipolare e raccomanda il monitoraggio e la gestione dei cambiamenti dei parametri metabolici (cambiamenti lipidici, iperglicemia e diabete mellito) e dell’aumento di peso durante l'uso del medicinale in tutte…
Leggi
The U.S. Food and Drug Administration has strengthened the warning for the type 2 diabetes medicine canagliflozin related to the increased risk of bone fractures and added new information about decreased bone mineral density http://www.fda.gov/Drugs/DrugSafety/ucm461449.htm
Leggi
September 18, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm415180.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Leggi
September 24, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm416144.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Leggi
21/11/2014 http://www.agenziafarmaco.gov.it/sites/default/files/Testosterone-CMDh_IT.pdf
Leggi
FDA December 23, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm
Leggi
EMA December 19, 2014 http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002240.jsp&mid=WC0b01ac058004d5c1
Leggi
AIFA 04/02/2015 http://www.agenziafarmaco.gov.it/it/content/rapporto-osmed-i-farmaci-il-sistema-cardiovascolare-primi-consumo-e-spesa-convenzionata
Leggi
12/02/2015 http://www.agenziafarmaco.gov.it/it/content/diabete-di-tipo-2-l%E2%80%99fda-approva-nuova-combinazione-di-farmaci
Leggi
March 25, 2015 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm439838.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Leggi
